Learn about the latest advancements in the treatment of malignant & metastatic brain tumors in areas such as immunotherapy, radiation, and surgery.
About a third of lung cancer patients will also develop brain metastases. This webinar will explore life with brain mets and lung cancer, including risks, progression, signs & symptoms, treatment options,
New and updated resources from the ABTA can help you navigate brain tumor treatment and care decisions and receive personalized support.
A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.
ABTA Chief Mission Officer Nicole Willmarth, PhD, was recognized for her efforts to advance brain tumor research at the 26th Society for Neuro-Oncology (SNO) Annual Meeting.